The saudi experience in fludarabine-based conditioning regimens in patients with fanconi anemia undergoing stem cell transplantation: Excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 4, 2012, Pages 627-632

  Ayas, Mouhab ^a   Al Seraihi, Amal ^a   El Solh, Hassan ^a   Al Ahmari, Ali ^a   Khairy, Ashraf ^a   Aldali, Abdelmoneim ^a   Markiz, Samer ^a   Siddiqui, Khawar ^a   Al Jefri, Abdullah ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Antithymocyte globulin; Cyclophosphamide; Graft versus host disease; Radiation

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ARTICLE; BONE MARROW CELL; CAUSE OF DEATH; CHILD; CHIMERA; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REGIMEN; DRUG TOLERABILITY; ENGRAFTMENT; FANCONI ANEMIA; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HLA MATCHING; HUMAN; LIVER VENOOCCLUSIVE DISEASE; MALE; MUCOSA INFLAMMATION; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROSPECTIVE STUDY; RECIPIENT; SAUDI ARABIA; SCHOOL CHILD; SEPSIS; SEROLOGY; SHORT TANDEM REPEAT; UNRELATED DONORS;

ADOLESCENT; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; CYCLOPHOSPHAMIDE; CYSTITIS; DISEASE-FREE SURVIVAL; FANCONI ANEMIA; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; PROSPECTIVE STUDIES; SAUDI ARABIA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS; VIDARABINE;

EID: 84858080035     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.08.015     Document Type: Article

References (29)

1. Ayas M., Solh H., Mustafa M.M., et al. Bone marrow transplantation from matched siblings in patients with Fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant 2001, 27:139-143.
2. Ayas M., Al-Jefri A., Al-Mahr M., et al. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy. Bone Marrow Transplant 2005, 35:463-466.
3. Ayas M., Al-Jefri A., Al-Seraihi A., et al. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 years' experience. Bone Marrow Transplant 2008, 42(Suppl 1):S45-S48.
4. Ayas M., Al-Jefri A., Al-Seraihi A., et al. Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: update on the Saudi experience. Bone Marrow Transplant 2008, 41:261-265.
5. Farzin A., Davies S.M., Smith F.O., et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience. Br J Haematol 2007, 136:633-640.
6. Dufour C., Rondelli R., Locatelli F., et al. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO. Br J Haematol 2001, 112:796-805.
7. Pasquini R., Carreras J., Pasquini M.C., et al. HLA-matched Sibling Hematopoietic Stem Cell Transplantation for Fanconi Anemia: Comparison of Irradiation and Nonirradiation Containing Conditioning Regimens. Biol Blood Marrow Transplant 2008, 14:1141-1147.
8. Bonfim C.M., De Medeiros C.R., Bitencourt M.A., et al. HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. Biol Blood Marrow Transplant 2007, 13:1455-1460.
9. Ertem M., Ileri T., Azik F., et al. Related donor hematopoietic stem cell transplantation for Fanconi anemia without radiation: a single-center experience in Turkey. Pediatr Transplant 2009, 13:88-95.
10. Stepensky P., Shapira M.Y., Balashov D., et al. Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning. Biol Blood Marrow Transplant 2011, 17:1282-1288.
11. Locatelli F., Zecca M., Pession A., et al. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. Haematologica 2007, 92:1381-1388.
12. Tan P.L., Wagner J.E., Auerbach A.D., et al. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 2006, 46:630-666.
13. George B., Mathews V., Shaji R.V., et al. Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia. Bone Marrow Transplant 2005, 35:341-343.
14. Bitan M., Or R., Shapira M.Y., et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 2006, 12:712-718.
15. Thakar MS, Kurre P, Storb R, et al. Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation. Bone Marrow Transplant. 201;46:539-544.
16. Baker J.M., Lewis V.A., Fernandez C.V., et al. Allogeneic hematopoietic stem cell transplantation of patients with FA and high-risk features using fludarabine without radiation. Pediatr Blood Cancer 2009, 52:683-685.
17. Chaudhury S., Auerbach A.D., Kernan N.A., et al. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol 2008, 140:644-655.
18. Deeg H.J., Socié G., Schoch G., et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996, 87:386-392.
19. Rosenberg P.S., Greene M.H., Alter B.P. Cancer incidence in persons with Fanconi anemia. Blood 2003, 101:822-826.
20. Gluckman E., Wagner J.E. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant 2008, 41:127-132.
21. Masserot C., Peffault de Latour R., Rocha V., et al. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Cancer 2008, 113:3315-3322.
22. MacMillan M.L., Wagner J.E. Haematopoeitic cell transplantation for Fanconi anaemia: when and how?. Br J Haematol 2010, 149:14-21.
23. Gluckman E., Rocha V., Ionescu I., et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007, 13:1073-1082.
24. Guardiola P., Socié G., Li X., et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood 2004, 103:73-77.
25. Dalle J.H. HSCT for Fanconi anemia in children: factors that influence early and late results. Bone Marrow Transplant 2008, 42(Suppl 2):S51-S53.
26. Yesilipek M.A., Karasu G.T., Kupesiz A., et al. Better posttransplant outcome with fludarabine based conditioning in multitransfused Fanconi anemia patients who underwent peripheral blood stem cell transplantation. J Pediatr Hematol Oncol 2009, 31:512-515.
27. Turkistani W., Ashour M., Al-Mojalli H., et al. Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine. Bone Marrow Transplant 2010, 45:415-416.
28. Wagner J.E., Eapen M., MacMillan M.L., et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007, 109:2256-2262.
29. Ayas M., Al-Mahr M., Al-Jefri A., et al. Does adding ATG to the GVHD prophylaxis regimen help reduce its incidence? (letter to the editor). Bone Marrow Transplant 2003, 31:311.